Pfizer, Astellas prostate cancer drug succeeds key trial
(Reuters) - Pfizer Inc and Japan's Astellas Pharma Inc said on Thursday their prostate cancer drug met the main goal of a trial testing it for a more common form of the disease.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Cancer | Cancer & Oncology | Health | Japan Health | Pfizer | Pharmaceuticals | Prostate Cancer